Cargando…

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome

OBJECTIVE: To investigate dopaminergic function in a large cohort of patients with corticobasal syndrome (CBS) and describe its relationship with clinical features in comparison to Parkinson's disease and healthy control subjects. In addition, we assessed prevalence and features of individuals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cilia, Roberto, Rossi, Carlo, Frosini, Daniela, Volterrani, Duccio, Siri, Chiara, Pagni, Cristina, Benti, Riccardo, Pezzoli, Gianni, Bonuccelli, Ubaldo, Antonini, Angelo, Ceravolo, Roberto
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085517/ https://www.ncbi.nlm.nih.gov/pubmed/21559307 http://dx.doi.org/10.1371/journal.pone.0018301

Ejemplares similares

Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022)

Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome
por: Unti, Elisa, et al.
Publicado: (2019)

The Epidemiology and Clinical Manifestations of Dysexecutive Syndrome in Parkinson’s Disease
por: Ceravolo, Roberto, et al.
Publicado: (2012)

Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay
por: Cammisuli, Davide Maria, et al.
Publicado: (2021)

Non-pharmacological interventions for Parkinson's disease mild cognitive impairment: future directions for research
por: Cammisuli, Davide Maria, et al.
Publicado: (2020)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Molecular Imaging of the Dopamine Transporter
por: Palermo, Giovanni, et al.
Publicado: (2019)

Freezing of gait and dementia in parkinsonism: A retrospective case–control study
por: Palermo, Giovanni, et al.
Publicado: (2019)

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
por: Palermo, Giovanni, et al.
Publicado: (2020)

Transcranial Direct Current Stimulation (tDCS) as a Useful Rehabilitation Strategy to Improve Cognition in Patients With Alzheimer's Disease and Parkinson's Disease: An Updated Systematic Review of Randomized Controlled Trials
por: Cammisuli, Davide Maria, et al.
Publicado: (2022)

Quantitative susceptibility mapping in atypical Parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2019)

Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019)

Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease
por: Elefante, Camilla, et al.
Publicado: (2021)

Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS study
por: Barone, Paolo, et al.
Publicado: (2019)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review
por: Palermo, Giovanni, et al.
Publicado: (2021)

Glucocerebrosidase mutations in primary parkinsonism
por: Asselta, Rosanna, et al.
Publicado: (2014)

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
por: Del Prete, Eleonora, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

A molecular signature in blood identifies early Parkinson’s disease
por: Molochnikov, Leonid, et al.
Publicado: (2012)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
por: Daniele, Simona, et al.
Publicado: (2018)

Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
por: Albrecht, Franziska, et al.
Publicado: (2017)

Social Cognition and Oxytocin in Huntington’s Disease: New Insights
por: Unti, Elisa, et al.
Publicado: (2018)

Disease-related patterns of in vivo pathology in Corticobasal syndrome
por: Niccolini, Flavia, et al.
Publicado: (2018)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008)

Clinicopathologic analysis of progressive non-fluent aphasia and corticobasal degeneration: Case report and review
por: de Brito-Marques, Paulo Roberto, et al.
Publicado: (2011)

Rapidly Progressive Corticobasal Degeneration Syndrome
por: Valverde, Ana Herrero, et al.
Publicado: (2011)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)

Apraxia and Motor Dysfunction in Corticobasal Syndrome
por: Burrell, James R., et al.
Publicado: (2014)

Corticobasal syndrome: A diagnostic conundrum
por: Parmera, Jacy Bezerra, et al.
Publicado: (2016)

Neuropathology and emerging biomarkers in corticobasal syndrome
por: Koga, Shunsuke, et al.
Publicado: (2022)

Neuronal Antibody-Associated Corticobasal Syndrome
por: Gupta, Anu, et al.
Publicado: (2023)

Loss of thalamic serotonin transporters in early drug-naïve Parkinson’s disease patients is associated with tremor: an [(123)I]β-CIT SPECT study
por: Caretti, V., et al.
Publicado: (2008)

Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
por: Pitkonen, Miia, et al.
Publicado: (2012)

Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT
por: Neill, Matthew, et al.
Publicado: (2021)

Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7t0kc2utonkdrt97m5mrp07rsh